APA

Kaldor S. W., Kalish V. J., Davies J. F., Shetty B. V., Fritz J. E., Appelt K., Burgess J. A., Campanale K. M., Chirgadze N. Y., Clawson D. K., Dressman B. A., Hatch S. D., Khalil D. A., Kosa M. B., Lubbehusen P. P., Muesing M. A., Patick A. K., Reich S. H., Su K. S. & Tatlock J. H. (19980112). Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 protease. : Journal of medicinal chemistry.

Chicago

Kaldor S W, Kalish V J, Davies J F, Shetty B V, Fritz J E, Appelt K, Burgess J A, Campanale K M, Chirgadze N Y, Clawson D K, Dressman B A, Hatch S D, Khalil D A, Kosa M B, Lubbehusen P P, Muesing M A, Patick A K, Reich S H, Su K S and Tatlock J H. 19980112. Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 protease. : Journal of medicinal chemistry.

Harvard

Kaldor S. W., Kalish V. J., Davies J. F., Shetty B. V., Fritz J. E., Appelt K., Burgess J. A., Campanale K. M., Chirgadze N. Y., Clawson D. K., Dressman B. A., Hatch S. D., Khalil D. A., Kosa M. B., Lubbehusen P. P., Muesing M. A., Patick A. K., Reich S. H., Su K. S. and Tatlock J. H. (19980112). Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 protease. : Journal of medicinal chemistry.

MLA

Kaldor S W, Kalish V J, Davies J F, Shetty B V, Fritz J E, Appelt K, Burgess J A, Campanale K M, Chirgadze N Y, Clawson D K, Dressman B A, Hatch S D, Khalil D A, Kosa M B, Lubbehusen P P, Muesing M A, Patick A K, Reich S H, Su K S and Tatlock J H. Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 protease. : Journal of medicinal chemistry. 19980112.